Skip to main content

ADVERTISEMENT

Cantidio Campos Neto, BS , PhD

Original Contribution
06/15/2017
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes...
06/15/2017
Journal of Invasive Cardiology
Cardiovascular Risk Stratification for Patients Treated With Drug-Eluting Stents: Development and Validation of the DESIRE Score
Original Contribution
03/01/2020
We developed a risk score to estimate the risk of major adverse cardiac event (MACE) during the in-hospital and long-term follow-up periods after PCI with drug-eluting stent (DES) implantation.
We developed a risk score to estimate the risk of major adverse cardiac event (MACE) during the in-hospital and long-term follow-up periods after PCI with drug-eluting stent (DES) implantation.
We developed a risk score to...
03/01/2020
Journal of Invasive Cardiology